Neuronetics
- Revenue$49.2 MFY, 2020
- Market Capitalization$89.1 M2022-06-24
OverviewSuggest Edit
Neuronetics is a medical device company. It develops non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. In addition, the Company provides NeuroStar TMS Therapy (transcranial magnetic stimulation), a non-invasive form of neuromodulation.
| Type | Public | |
| Founded | 2003 | |
| HQ | Malvern, PA, US | Map |
| Website | neurostar.com | |
| Employee Ratings |
Recent NewsAll News
- Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
- Neuronetics Reports First Quarter 2022 Financial and Operating Results
- Neuronetics and Transformations Care Network Announce Extended Commercial Partnership
- Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
Key People/Management at Neuronetics
Charles E. Larsen
Co-Founder
Mark A. Demitrack
Chief Medical Officer
Kevin Bitterman
Director
Mary Hailey
VP of Health Policy and Government Relations
Neuronetics Office Locations
Neuronetics has an office in Malvern
Malvern, PA, US (HQ)
31 General Warren Blvd
Neuronetics Financials and Metrics
Neuronetics Revenue
Neuronetics's revenue was reported to be $49.24 m in FY, 2020
| USD | |
|---|---|
Revenue (Q1, 2021) | 12.3m |
Gross profit (Q1, 2021) | 10.1m |
Gross profit margin (Q1, 2021), % | 81.9% |
Net income (Q1, 2021) | (7.9m) |
EBIT (Q1, 2021) | (6.9m) |
Market capitalization (24-Jun-2022) | 89.1m |
Closing stock price (24-Jun-2022) | 3.4 |
Cash (31-Mar-2021) | 121.3m |
EV | 3.2m |
Neuronetics's current market capitalization is $89.1 m.
Annual
Annual
Annual
Quarterly
| USD | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | (13.0m) | (18.0m) | (7.5m) | (14.6m) | (21.5m) | (12.6m) | (20.4m) | (23.8m) | (7.9m) |
Depreciation and Amortization | 463.0k | 671.0k | 204.0k | 457.0k | 765.0k | 301.0k | 534.0k | 741.0k | 281.0k |
Inventories | (378.0k) | (767.0k) | 59.0k | (82.0k) | (455.0k) | (104.0k) | (557.0k) | (1.0m) | (1.7m) |
Accounts Payable | (89.0k) | (594.0k) | (1.5m) | (228.0k) | 10.0k | (1.3m) | (2.4m) | (2.3m) | (694.0k) |
| USD | Q2, 2018 |
|---|---|
Revenue/Employee | 70.5k |
Debt/Equity | -0.1 x |
Debt/Assets | 1.1 x |
Financial Leverage | -0.1 x |
Neuronetics Cybersecurity Score
Neuronetics Environment, Social & Governance (ESG) Ratings
Neuronetics Online and Social Media Presence
1.22k Twitter followers
Neuronetics has 1.22k Twitter Followers. The number of followers has increased 0.2% month over month and increased 1.2% quarter over quarter
Neuronetics's Trends
Twitter Engagement Stats for @TMSTherapy
892
Tweets
886
Following
1.2k
Followers
9
Tweets last 30 days
0.6
Avg. likes per Tweet
55.6%
Tweets with engagement
Neuronetics News and Updates
May 25, 2022
Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders, today announced that …
May 12, 2022
Neuronetics Reports First Quarter 2022 Financial and Operating Results
MALVERN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world, today announced its fina…
May 11, 2022
Neuronetics and Transformations Care Network Announce Extended Commercial Partnership
MALVERN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world, today announced an exten…
May 11, 2022
Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
NeuroStar data from largest depression outcomes registry in the world to be highlighted NeuroStar data from largest depression outcomes registry in the world to be highlighted
May 11, 2022
Neuronetics Files Federal Lawsuit Against Brainsway for Misleading Psychiatrists and Patients
MALVERN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the filing of…
April 28, 2022
Neuronetics to Report First Quarter 2022 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 28, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it pla…
Neuronetics Blogs
March 01, 2022
MT Cap for NeuroStar Advanced Therapy for Mental Health Now Available Nationwide
MT Cap for NeuroStar Advanced Therapy for Mental Health Now Available Nationwide
Content Import
Tue, 03/01/2022 - 08:36
MT Cap for NeuroStar Advanced Therapy for Mental Health Now Available Nationwide
03/01/22
This release is a backfill from a News Wire
…
July 14, 2021
Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers
The redesigned My NeuroStar Resource Center provides user-friendly tools to help practices expand awareness of NeuroStar® Advanced Therapy for Mental Health MALVERN, Pa. , July 14, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on
May 17, 2021
Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center
The market leader in transcranial magnetic stimulation therapy celebrates leading provider of NeuroStar Advanced Therapy for Mental Health MALVERN, Pa. , May 17, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing
January 12, 2021
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results
MALVERN, Pa. , Jan. 12, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today, in advance of the
December 08, 2020
Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners
Amendment provides Neuronetics with available and flexible funding options through 2022 MALVERN, Pa. , Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality
November 23, 2020
Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
TouchStar theta burst protocol leverages NeuroStar® Advanced Therapy’s patented Contact Sensing technology to help ensure the optimum prescribed treatment dose to patients MALVERN, Pa. , Nov. 23, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology
Neuronetics Frequently Asked Questions
When was Neuronetics founded?
Neuronetics was founded in 2003.
Who are Neuronetics key executives?
Neuronetics's key executives are Charles E. Larsen, Mark A. Demitrack and Kevin Bitterman.
How many employees does Neuronetics have?
Neuronetics has 235 employees.
What is Neuronetics revenue?
Latest Neuronetics annual revenue is $49.2 m.
What is Neuronetics revenue per employee?
Latest Neuronetics revenue per employee is $209.5 k.
Who are Neuronetics competitors?
Competitors of Neuronetics include Tombot, Healthcare RM and ncgCARE.
Where is Neuronetics headquarters?
Neuronetics headquarters is located at 31 General Warren Blvd, Malvern.
Where are Neuronetics offices?
Neuronetics has an office in Malvern.
How many offices does Neuronetics have?
Neuronetics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies